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Abstract
Background: The relationship between behavioral
changes and functional decline in frontotemporal de-
mentia (FTD) is not well understood. Methods: Thirty-
nine patients (21 behavioral variant FTD [bvFTD],
18 semantic variant primary progressive aphasia
[svPPA]) were followed up longitudinally (2–4 years
follow-up). Functional (Disability Assessment for De-
mentia) and behavioral (Cambridge Behavioural In-
ventory Revised) assessments were included for
between-group (pairwise comparisons, mixed model
analysis) and within-group analyses (bivariate corre-
lations). Results: Functionally, patients with bvFTD
were more impaired than patients with svPPA at
baseline and continued to be at follow-up, despite
similar disease duration. By contrast, behavioral
impairments differed between patient groups at
baseline and at follow-up. At baseline, patients with
bvFTD exhibited higher levels of apathy and changes
in eating than patients with svPPA; disinhibited and stereotypical behaviors were similar.
Over the years, patients with bvFTD showed reduction in disinhibition and stereotypical be-
havior while apathy and eating changes increased. By contrast, all measured behaviors in-
creased in patients with svPPA over time. Finally, only apathy made longitudinal
contributions to functional disability in patients with svPPA, whereas apathy and stereotyp-
ical behavior were associated with increased disability in patients with bvFTD. Conclusions:
Despite shared overlapping baseline behavioral symptoms, patients with bvFTD are more
functionally impaired than patients with svPPA. Apathy has a strong role in disability for both
bvFTD and svPPA, but stereotypical behaviors only contributed to functional deficits in
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patients with bvFTD. Our findings suggest that rigid/compulsive behaviors may in fact sup-
port activity engagement in patients with svPPA. Taken together, our results indicate that
interventions to reduce disability in the FTD spectrum require an alternative rationale in
comparison to Alzheimer disease dementia, and should carefully weigh the interaction of be-
havioral symptoms and functional status. Neurol Clin Pract 2016;6:1–10
F
rontotemporal dementia (FTD) impinges markedly on everyday function1–3 but the
degree and nature of functional disability depends on the clinical presentation.
Specifically, a gradient of functional disability exists across the 3 primary clinical
FTD subtypes: patients with behavioral variant FTD (bvFTD) are severely im-
paired, followed by nonfluent variant primary progressive aphasia (nfvPPA) and semantic
variant primary progressive aphasia (svPPA).1,4 Despite functional differences between bvFTD
and svPPA, patients can share similar behavioral profiles; yet for patients with svPPA, this is
often less noted due to the severe and prevalent language and semantic deficits.5,6 nfvPPA, on
the other hand, elicits a comparatively mild behavioral profile, and for this reason it was not
included in the present study.
The nature of functional disability in FTD variants is likely to be a direct reflection of the
specific behavioral and cognitive changes seen in each syndrome.2,7 There is well-reported
overlap of behavioral symptoms between bvFTD and svPPA.5,6 It is critical to investigate
the role of behavioral changes in functional disability; once independent factors are identified,
novel interventions can be developed to reduce disability.
We hypothesized that similar levels of behavioral symptoms across bvFTD and svPPA
would be present, but their specific contribution to functional disability would differ. The
study aimed to (1) determine baseline function and behavior status in bvFTD and svPPA;
(2) examine longitudinal functional and behavioral changes; and (3) examine relationships be-
tween functional and behavioral changes longitudinally.
METHODS
Participants
Thirty-nine individuals diagnosed with FTD (bvFTD5 21; svPPA 5 18) and their caregivers
were recruited from FRONTIER, the frontotemporal dementia research group based in
Sydney, Australia. All patients met current criteria for either possible or probable bvFTD or
svPPA8,9 and diagnoses were based on a multidisciplinary consensus (neurologist and neuropsy-
chologist). Study participants were assessed in the clinic, home, or care facility on 2–4 separate
occasions approximately 16 months between each assessment (mean 16.4 6 8.2) between
November 2007 and January 2012, with 200 individual assessments completed in total.
Participants were included if they had a close relative or friend informant who could reliably
report on the person’s behavior and everyday routine, did not have major depression, and did
not have any physical disability that could influence ability to undertake activities of daily
living (ADLs). The ADL measure included in this study was not used in the diagnostic
process. Disease duration was estimated from the onset of symptoms as described by the
informant at the time of diagnosis.
Standard protocol approvals, registrations, and patient consents
This study was approved by the University of New South Wales and the South Eastern Sydney
and Illawarra Area Health Service human ethics committees. Written informed consent was
obtained from each patient or primary caregiver where appropriate.
Instruments
Functional assessment ADLs were assessed with the Disability Assessment for Dementia
(DAD),10 an informant-based scale made up of 17 items pertaining to basic ADLs and 23
to instrumental ADLs. Basic ADL items include hygiene, dressing, continence, and eating;
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instrumental ADL items include meal preparation, telephoning, going on an outing, finance
and correspondence, medications, and leisure and housework. In order to avoid bias towards
certain activities (e.g., meal preparation or housework), nonapplicable questions are omitted
from the final score and the score is reported as a percentage. Greater impairment is indicated
by lower DAD scores.
In order to further distinguish baseline clinical differences between the groups, basic ADL
and instrumental ADL subscores were included in the analysis in addition to total DAD scores.
All caregivers were interviewed by a research occupational therapist (EM or CO) at baseline and
at each follow-up visit.
Behavioral assessment The Cambridge Behavioural Inventory Revised (CBI-R)11 is
a caregiver-completed assessment that comprises 45 items assessing behavior across 10
domains. Each question requires the caregiver to rate behavior on a 5-point scale (0 5
never, 1 5 a few times per month, 2 5 a few times per week, 3 5 daily, and 4 5
constantly), with higher scores indicating higher frequency of abnormal behavior. Data
for 4 behavioral subsections commonly associated with FTD9,12,13 were used: disinhibition
(e.g., exhibiting socially embarrassing behavior; making inappropriate comments), stereo-
typical behaviors (e.g., adhering to rigid daily routines; being obsessive about watching the
time), apathy (e.g., lacking motivation or enthusiasm; appearing indifferent), and eating
changes (e.g., eating more sweet/fatty foods then before; declining table manners such as
stuffing food into the mouth; eating an extremely restricted diet of specific foods). Sub-
section scores were converted to percentages to allow for domain comparison; higher scores
represent greater behavioral change.
General cognitive assessment At baseline, all participants were administered the Adden-
brooke’s Cognitive Examination Revised (ACE-R).14 The ACE is a brief screening tool
sensitive to the early stages of dementia, which assesses 5 cognitive domains: attention and
orientation, memory, verbal fluency, language, and visuospatial abilities. The total score is
100, where lower scores indicate more impaired cognitive functioning. The cutoff of 88/100
yields 89% specificity and 94% sensitivity for diagnosing dementia.
Data analyses
Statistical analyses were performed using SPSS 21.0 (IBM, Armonk, NY) for Windows.
Demographic data across both patient groups were compared using parametric independent
sample t tests and x2 tests for sex comparisons. Normality of distribution of baseline
variables was assessed using Kolmogorov-Smirnov tests, and due to skewed data, nonpara-
metric measures (Mann-Whitney U) were used for pairwise comparisons at baseline. To
examine changes in function and behavior between the diagnostic categories over time,
linear mixed-effect models were applied. Mixed model analyses allow for accounting for
missing data,15 which was relevant in the current data, as the number of people who had
follow-up assessments declined with each year. DAD data for bvFTD declined across the 4
visits as follows: n 5 21, n 5 16, n 5 6, and n 5 2; for svPPA: n 5 18, n 5 10, n 5 10,
and n 5 4. CBI-R data for bvFTD declined across visits: n 5 21, n 5 20, n 5 8, and
n 5 5; for svPPA: n 5 18, n 5 15, n 5 11, and n 5 5. Fixed effects in the model included
time, diagnostic category (bvFTD or svPPA), and the interaction between time and di-
agnostic category. Individual patient variability at baseline was the only random effect
included; hence a random intercept was included in each model. Both the fixed and random
effects in the model determined the variability of any estimated parameters. Separate models
were built for each of the following dependent variables: DAD total, DAD instrumental
ADLs, DAD basic ADLs, CBI-R Disinhibition, CBI-R Stereotypical behavior, CBI-R
Apathy, and CBI-R Eating changes. Due to the small sample size, a linear first-order
polynomial was applied in the analysis. For any given model, a significant effect for time
would indicate that the dependent variable changes over time, and a significant interaction
between time and diagnostic category would indicate that bvFTD and svPPA have different
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changes in the dependent variable over time. To examine longitudinal relationships between
behavioral variables and ADL function within groups, subject means for each CBI and
DAD variable were calculated across observations. Pearson correlation was then calculated
between these subject means and a weighted correlation coefficient was applied to account
for the different number of observations across subjects.16 Bonferroni corrections were
applied for multiple comparisons.
RESULTS
Demographics
The 2 clinical groups were matched for age, sex distribution, education, and disease duration.
The bvFTD group scored higher than the svPPA group on global cognition ACE-R, reflecting
the language load of this task (table 1).
Baseline assessment
Pairwise comparisons revealed that patients with bvFTD scored lower than the svPPA group at
baseline across all ADL scores (table 1) despite matched disease duration.
To investigate degrees of behavioral changes between groups, CBI-R percentage scores were
categorized as absent (score5 0); mild/moderate (score 5 1–50); or severe/very severe (score 5
51–100). As shown in figure 1, A and B, levels of disinhibition and stereotypical behavior
were similar for bvFTD and svPPA. In contrast, patients with bvFTD had higher scores for
apathy and eating changes, reflecting more marked neuropsychiatric changes in this subgroup
(table 1). A striking group difference was detected in regards to apathy (table 1), where 71.5%
of patients with bvFTD exhibited severe/very severe apathy compared with 33.3% of patients
with svPPA (figure 1C). Changes in eating behavior were present in 100% of patients with
bvFTD, with half of them being reported as presenting with severe/very severe changes,
Table 1 Demographic characteristics and behavioral and functional outcomes in behavioral variant frontotemporal
dementia (bvFTD) and semantic variant primary progressive aphasia (svPPA)
bvFTD (n 5 21) svPPA (n 5 18) Statistic test p Values
Age, y 62.1 (10.5) 63.7 (7.8) t 5 21.095 NSa
Sex, M/F 14/7 12/6 x2 5 0.116 NSb
Education, y 12.2 (3.0) 12.1 (3.6) t 5 0.125 NSa
Disease duration, y 3.5 (2.4) 4.6 (2.3) t 5 21.512 NSa
Baseline ACE-R score, max 100, cutoff 88/100 74.7 (10.0) 56.8 (15.6) t 5 4.173 ,0.001a
DAD: Total score 52.5 (31–65) 87.5 (63–93) U 5 47 ,0.01c
DAD: Instrumental ADLs 35 (9–46) 81.8 (45–90) U 5 40 ,0.005c
DAD: Basic ADLs 64.7 (57–88) 94.1 (76–100) U 5 53 ,0.01c
CBI-R: Disinhibition 33.3 (19–60) 16.7 (3–39) U 5 121.5 NSc
CBI-R: Stereotypical behavior 56.3 (34–78) 46.9 (5–81) U 5 163 NSc
CBI-R: Apathy 85 (48–95) 23.6 (5–68) U 5 79 ,0.005c
CBI-R: Eating changes 50 (28–69) 6.3 (0–39) U 5 58.5 ,0.001c
Abbreviations: ACE-R 5 Addenbrooke’s Cognitive Examination–Revised; CBI-R 5 Cambridge Behavioural Inventory–Revised; DAD 5
Disability Assessment for Dementia; NS 5 not significant.
Disease duration refers to the time between symptom onset and baseline assessment date.
a Independent samples t test. Scores are means (SD).
bx2 test using Yates correction.
cMann-Whitney U test, 2-tailed. Scores are medians (25th–75th percentile) for all variables.
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whereas alterations in eating habits were reported in only 56% of patients with svPPA and the
majority were mild/moderate changes (figure 1D).
Longitudinal changes
ADL function declined over time in both groups, with bvFTD worse than svPPA on all DAD
scores: total ADLs (F1,53.09 5 79.30, p , 0.001); instrumental ADLs (F1,54.91 5 48.78, p ,
0.001); and basic ADLs (F1,52.92 5 54.87, p , 0.001). For basic ADLs specifically, patients
with bvFTD exhibited a more rapid decline than patients with svPPA (F1,52.92 5 4.57, p ,
0.05; figure 2C). Of note, the bvFTD group was near floor performance on the total DAD by
year 3 (figure 2A), while patients with svPPA were still performing at around 55% of ability
in relation to their premorbid levels.
Longitudinal changes in levels of disinhibition (F1,72.84 5 11.05, p , 0.005) and stereo-
typical behavior (F1,72.46 5 11.28, p , 0.005) differed between bvFTD and svPPA despite
the 2 groups showing similar levels on these measures at baseline. svPPA demonstrated
increasing levels of these behaviors over time, whereas both behaviors declined in bvFTD
(figure 2, D and E). Levels of apathy (F1,75.34 5 16.61, p , 0.001) and eating changes
(F1,74.68 5 26.79, p , 0.001) increased at a similar rate over time for both groups; however,
patients with bvFTD continued to exhibit higher levels of these behaviors than patients with
svPPA (figure 2, F and G).
Longitudinal correlations
Pearson correlations using subject means and weighted correlation coefficients were conducted
to examine relationships between decline in ADL function (DAD subscores) and behavioral
changes (CBI behavioral scores) over time (table 2). For bvFTD, decline in both total ADL
and instrumental ADL scores were associated with apathy (r 5 20.512, p , 0.001; r 5
20.586, p , 0.001), while decline in basic ADLs was correlated with stereotypical behavior
Figure 1 Percentage distribution according to severity of baseline behavioral changes in
behavioral variant frontotemporal dementia (bvFTD) and semantic variant primary
progressive aphasia (svPPA) cohorts
(A–D) Behavioral change absent, mild/moderate, or severe/very severe.
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(r 5 0.329, p , 0.015). For svPPA, apathy correlated with both total ADLs (r 5 20.514,
p , 0.005) and instrumental ADLs (r 5 20.583, p , 0.001).
DISCUSSION
Marked overlapping behavioral changes in bvFTD and svPPA dissociate over time: behavioral
changes become less pronounced in bvFTD but increase in svPPA. Importantly, decline in everyday
function was associated with increased apathy in bvFTD and svPPA. Stereotypical behavior and
ADL decline was only associated with disability in patients with bvFTD, despite comparable levels
of stereotypical behavior at baseline in both groups. In comparison, disinhibition per se did not
seem to make a direct contribution to functional decline over time for either group. Taken together,
our results confirm previous findings of more severe functional impairment in bvFTD than in
svPPA, and we confirmed that this difference in functional status continues as the disease progresses.
The correlation between apathy and worsening function demonstrated in both bvFTD and
svPPA is perhaps not surprising given that as apathy increases, a person is less likely to
Figure 2 Model representations of performance on functional and behavioral measures
over time for behavioral variant frontotemporal dementia (bvFTD) and sematic
variant primary progressive aphasia (svPPA) (plots model representations of
scores)
(A–G) ADL 5 activities of daily living; BADL 5 basic activities of daily living; CBI 5 Cambridge Behavioural Inventory;
DAD 5 Disability Assessment for Dementia; IADL 5 instrumental activities of daily living.
Marked overlapping behavioral changes in
bvFTD and svPPA dissociate over time:
behavioral changes become less pronounced in
bvFTD but increase in svPPA.
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participate in daily activities. This association has also been reported in Alzheimer disease (AD),
where apathy, anxiety, and aberrant motor disturbance correlate with functional disability.17–19
The longitudinal link between apathy and functional decline in bvFTD reported here also
supports findings from previous cross-sectional studies.2,7
Across both patient groups, disinhibition did not play a major role in functional impair-
ment. By contrast, apathy, sometimes regarded as the flip side of disinhibition, was detri-
mental to functional activities as patients failed to initiate them. In the present study,
apathy and changes in eating habits continue to increase throughout progression in both
bvFTD and svPPA. In contrast, disinhibited and stereotypical behaviors, which are often
difficult to manage, ameliorate over time in bvFTD while continuing to worsen in svPPA.
A possible reason for this may be the differing rates of disease progression: patients with
bvFTD decline faster into frank apathy, which may restrict the concurrent expression of
other symptoms, while patients with svPPA have a protracted disease progression. Past stud-
ies have reported a pattern of behavioral fluctuation over time in bvFTD, where patients may
became more docile and compliant as some challenging behaviors disappear throughout dis-
ease progression,20 or new behaviors appear in later stages.6,21–23 Comparable findings of
behavioral fluctuations along dementia progression have been described in the AD de-
mentia literature,24,25 reflecting the complex nature of neuropsychiatric symptoms in neu-
rodegenerative diseases.
The contribution of stereotypical behaviors to function seems to vary in bvFTD and svPPA.
In bvFTD, decline in stereotypical behaviors was associated with a reduction of participation in
basic daily functions. This association was not detected in svPPA, possibly due to the notewor-
thy increase of these behaviors over time. In fact, our results suggest that the presence of ste-
reotypical behaviors may serve as a compensatory support for continued participation in rigid
self-care routine tasks in patients with svPPA, which in turn show very mild decline even after 4
years.26,27 Closer examination at the specific dysfunctional behaviors reveals that the nature of
stereotypical behaviors is different. Patients with bvFTD are more likely to exhibit impulsive
behaviors, such as clapping or counting aloud, whereas patients with svPPA are prone to
adhere to a rigid routine and clock-watching.28,29 Similarly, longitudinal changes in eating
habits in svPPA seem to mirror their stereotypical behavior: rigid routines and bizarre choices
Table 2 Correlation matrix for repeated measures using subject means
CBI-R variables
bvFTD svPPA
Total DAD IADLs BADLs Total DAD IADLs BADLs
Disinhibition, r 20.200 20.290 20.092 20.107 20.252 0.138
Stereotypical behavior, r 0.214 0.081 0.329a 0.079 20.091 0.342
Apathy, r 20.512b 20.586b 20.317 20.514a 20.583b 20.348
Abbreviations: BADL 5 basic activities of daily living; bvFTD 5 behavioral variant frontotemporal
dementia; CBI-R 5 Cambridge Behavioural Inventory–Revised; DAD 5 Disability Assessment for
Dementia; IADL 5 instrumental activities of daily living; svPPA 5 semantic variant primary pro-
gressive aphasia.
Pearson correlation using subject means and weighted correlation coefficient (number of observa-
tions per subject).
aSignificance remains after Bonferroni corrections (p , 0.016).
bp , 0.001.
Across both patient groups, disinhibition did
not play a major role in functional impairment.
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around food commonly develop within the first few years in svPPA.27,30–32 Overeating is a com-
mon early feature in bvFTD and more so than in svPPA,33 which may be more related to lack of
inhibitory control. An interesting question for future research would be to confirm if the rigid/
compulsive nature of svPPA behaviors is more conducive to ADL performance, in particular for
basic activities. Indeed, patients with svPPA remain relatively independent in everyday tasks for
a much longer period of time, in line with a much more protracted disease progression.4,34,35
With disease progression, substantial overlap between FTD clinical variants arises, where
merging clinical characteristics between bvFTD and svPPA have been well-described.23,36 Find-
ings from this study highlight the early overlap of behavioral changes in both subgroups, which
has a direct repercussion on family caregiver burden37 that increases noticeably in svPPA.38
This study has some limitations, including the relatively small numbers of participants, with
declining numbers at each follow-up visit. Attrition of participants at follow-up is a common
phenomenon as patients become too impaired to return to research centers, and the small num-
bers included in this study could limit the generalizability of the results. The primary reasons
behind attrition were participants becoming too impaired to be followed up at the annual visits
or participants’ death. The use of the mixed model analysis provided more flexibility around
this limitation in the data. The use of informant report measures could be a potential bias if
caregivers underreport or overreport functional abilities and behaviors,39 but other studies
have shown a great benefit of using them with bvFTD groups.40
Overlapping marked behavioral changes are very well known in bvFTD and perhaps currently
less emphasized in svPPA.12 The present study offers novel insights into their distinct pro-
gression as well as diverse contribution to functional decline, where apathy is a clear negative
contributor to disability to both bvFTD and svPPA. This finding alone has clinical implica-
tions, as apathy could be an important consideration in the development of interventions to
improve functional performance in patients with FTD. Other factors underpinning disability in
svPPA are yet to be further investigated, but our findings suggest that the development of
treatments to slow functional decline in FTD (pharmacologic and nonpharmacologic) will need
to consider the specific contributions of neuropsychiatric symptoms to disability.
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